1
|
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1. Ann Oncol 2023; 34:920-933. [PMID: 37704166 DOI: 10.1016/j.annonc.2023.07.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 07/04/2023] [Accepted: 07/05/2023] [Indexed: 09/15/2023] Open
Abstract
BACKGROUND Patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint blockers (ICBs) ultimately progress either rapidly (primary resistance) or after durable benefit (secondary resistance). The cancer vaccine OSE2101 may invigorate antitumor-specific immune responses after ICB failure. The objective of ATALANTE-1 was to evaluate its efficacy and safety in these patients. PATIENTS AND METHODS ATALANTE-1 was a two-step open-label study to evaluate the efficacy and safety of OSE2101 compared to standard-of-care (SoC) chemotherapy (CT). Patients with human leukocyte antigen (HLA)-A2-positive advanced NSCLC without actionable alterations, failing sequential or concurrent CT and ICB were randomized (2 : 1) to OSE2101 or SoC (docetaxel or pemetrexed). Primary endpoint was overall survival (OS). Interim OS futility analysis was planned as per Fleming design. In April 2020 at the time of interim analysis, a decision was taken to prematurely stop the accrual due to coronavirus disease 2019 (COVID-19). Final analysis was carried out in all patients and in the subgroup of patients with ICB secondary resistance defined as failure after ICB monotherapy second line ≥12 weeks. RESULTS Two hundred and nineteen patients were randomized (139 OSE2101, 80 SoC); 118 had secondary resistance to sequential ICB. Overall, median OS non-significantly favored OSE2101 over SoC {hazard ratio (HR) [95% confidence interval (CI)] 0.86 [0.62-1.19], P = 0.36}. In the secondary resistance subgroup, OSE2101 significantly improved median OS versus SoC [11.1 versus 7.5 months; HR (95% CI) 0.59 (0.38-0.91), P = 0.017], and significantly improved post-progression survival (HR 0.46, P = 0.004), time to Eastern Cooperative Oncology Group (ECOG) performance status deterioration (HR 0.43, P = 0.006) and Quality of Life Questionnaire Core 30 (QLQ-C30) global health status compared to SoC (P = 0.045). Six-month disease control rates and progression-free survival were similar between groups. Grade ≥3 adverse effects occurred in 11.4% of patients with OSE2101 and 35.1% in SoC (P = 0.002). CONCLUSIONS In HLA-A2-positive patients with advanced NSCLC and secondary resistance to immunotherapy, OSE2101 increased survival with better safety compared to CT. Further evaluation in this population is warranted.
Collapse
Affiliation(s)
- B Besse
- Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France.
| | - E Felip
- Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona
| | - R Garcia Campelo
- Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Biomedical Research Institute, INIBIC, A Coruña
| | - M Cobo
- Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain
| | - C Mascaux
- Pneumology Department, Hôpitaux Universitaires de Strasbourg-Nouvel Hôpital Civil, Strasbourg
| | - A Madroszyk
- Medical Oncology Department, IPC-Institut Paoli-Calmettes, Marseille, France
| | - F Cappuzzo
- Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - W Hilgers
- Medical Oncology Department, Sainte Catherine Cancer Center, Avignon, France
| | - G Romano
- Medical Oncology Department, Ospedale Vito Fazzi-ASL Lecce, Lecce, Italy
| | - F Denis
- Medical Oncology Department, Institut Inter-Régional de Cancérologie Jean Bernard-Elsan, Le Mans, France
| | - S Viteri
- Medical Oncology Department, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Grupo Quironsalud, Barcelona, Spain
| | - D Debieuvre
- Pneumology Department, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
| | - D Galetta
- Medical Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari
| | - E Baldini
- Oncology Department, Ospedale San Luca, Lucca, Italy
| | - M Razaq
- Oncology Department, Stephenson Cancer Center, Oklahoma City, USA
| | - G Robinet
- Oncology Department, Centre Hospitalier Régional Universitaire Morvan, Brest, France
| | - M Maio
- Department of Oncology, University of Siena and Center for Immuno-Oncology, University Hospital, Siena
| | - A Delmonte
- Thoracic Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Meldola, Italy
| | - B Roch
- Thoracic Oncology Unit, Montpellier University, University Hospital of Montpellier, Montpellier
| | - P Masson
- Pneumology Department, Centre Hospitalier de Cholet, Cholet, France
| | - W Schuette
- Medical Oncology Department, Hospital Martha-Maria Halle-Doelau, Halle, Germany
| | - A Zer
- Thoracic Cancer Service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
| | - J Remon
- Paris-Saclay University, Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France
| | - D Costantini
- Medical Development Department, OSE Immunotherapeutics, Paris, France
| | - B Vasseur
- Medical Development Department, OSE Immunotherapeutics, Paris, France
| | - R Dziadziuszko
- Oncology and Radiotherapy Department and Early Phase Clinical Trials Centre, Medical University of Gdansk, Gdansk, Poland
| | - G Giaccone
- Meyer Cancer Center, Weill Cornell Medicine, New York, USA
| |
Collapse
|
2
|
Garbarino S, Latham L, Marzorati A, Gianazza S, Zullo A, Scorza A, Costantini D, Ballabio A, Inversini D, Ietto G, Carcano G. P-090 EMERGENCY INTRAPERITONEAL ONLAY MESH REPAIR OF INCARCERATED VENTRAL E INCISIONAL HERNIA. Br J Surg 2022. [DOI: 10.1093/bjs/znac308.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Aim
Abdominal wall hernia surgery is the frequent surgical operation. Incarceration and strangulation are the complications for patients going to emergency surgery clinics.Laparoscopic approach in emergency is controversial. IPOM treatment permits safe hernia reduction, accurate abdominal exploration,diagnosis and treatment of unknown hernia.
Material and Methods
in one year,we operated 12 urgent ventral hernia patients with IPOM technique. All patientsshowed hemodynamic stability. We evaluated safety of hernia reduction, conversion rate,operative time,hospital stay, and prosthesis infection.
Results
Nine patients underwent surgery for incarcerated incisional hernia, 3 patients for primary incarcerated ventral hernia. We used a laparoscopic approach. In 10 cases,we placed an intraperitoneal mesh. In two cases, we converted to open surgery, because of small bowel injury. It was never necessary to perform Intestinal resection for strangulated hernia.Contents of hernia sacs were omentum (7 patients), large bowel (1 patients), 4 omentum and small bowel (4 patients). Patients presented signs of small bowel obstruction. Average size of the defect was 6cm.Average operative time was 91 min, the mean post-operative hospital stay was 3.5 days. Post-operative complications weren't recorded. There wasn't mortality. During the follow-up none patients had mesh infection or hernia recurrence.
Conclusion
In emergency the Intraperitoneal Onlay Mesh Repair of Incarcerated Ventral and Incisional Hernia allowed safe adesiolysis, bowel reduction. Laparoscopic approach was associated to low post-operative complications even in emergency setting.
Collapse
Affiliation(s)
- S Garbarino
- Emergency and Transplantation Surgery , Ospedale di Circolo, Varese , Italy
| | - L Latham
- Emergency and Transplantation Surgery , Ospedale di Circolo, Varese , Italy
| | - A Marzorati
- Emergency and Transplantation Surgery , Ospedale di Circolo, Varese , Italy
| | - S Gianazza
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - A Zullo
- Emergency and Transplantation Surgery , Ospedale di Circolo, Varese , Italy
| | - A Scorza
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - D Costantini
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - A Ballabio
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - D Inversini
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - G Ietto
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| | - G Carcano
- Emergency and Transplantation Surgery, University of Insubria , Varese , Italy
| |
Collapse
|
3
|
Kotecki N, Champiat S, Delord JP, Vinceneux A, Jungels C, Marabelle A, Korakis I, Wojciekowski S, Block E, Clarke N, Fromond C, Poirier N, Costantini D, Vasseur B, Cassier P. 983P Phase I dose escalation study in patients (pts) with advanced solid tumours receiving first-in-class BI 765063, a selective signal-regulatory protein α (SIRPα) inhibitor, in combination with ezabenlimab (BI 754091), a programmed cell death protein 1 (PD-1) inhibitor. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1367] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
4
|
Besse B, Garcia Campelo M, Cobo Dols M, Quoix E, Madroszyk A, Felip E, Cappuzzo F, Denis F, Hilgers W, Romano G, Debieuvre D, Baldini E, Galetta D, Viteri S, Phan M, Schuette W, Zer A, Costantini D, Dziadziuszko R, Giaccone G. LBA47 Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2126] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
5
|
Mariani S, Costantini D, Lubrano C, Basciani S, Caldaroni C, Barbaro G, Poggiogalle E, Donini LM, Lenzi A, Gnessi L. Circulating SIRT1 inversely correlates with epicardial fat thickness in patients with obesity. Nutr Metab Cardiovasc Dis 2016; 26:1033-1038. [PMID: 27378396 DOI: 10.1016/j.numecd.2016.06.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Revised: 05/25/2016] [Accepted: 06/08/2016] [Indexed: 01/03/2023]
Abstract
BACKGROUND AND AIM Obesity is increasing worldwide and is related to undesirable cardiovascular outcomes. Epicardial fat (EF), the heart visceral fat depot, increases with obesity and correlates with cardiovascular risk. SIRT1, an enzyme regulating metabolic circuits linked with obesity, has a cardioprotective effect and is a predictor of cardiovascular events. We aimed to assess the relationship of EF thickness (EFT) with circulating SIRT1 in patients with obesity. METHODS AND RESULTS Sixty-two patients affected by obesity and 23 lean controls were studied. Plasma SIRT1 concentration was determined by enzyme-linked immunosorbent assay (ELISA). EFT was measured by echocardiography. Body mass index (BMI), waist circumference, heart rate (HR), blood pressure, and laboratory findings (fasting glucose, insulin, HbA1c, cholesterol, and triglycerides) were assessed. SIRT1 was significantly lower (P = 0.002) and EFT was higher (P < 0.0001) in patients with obesity compared with lean controls. SIRT1 showed a negative correlation with EFT and HR in the obesity group (ρ = -0.350, P = 0.005; ρ = -0.303, P = 0.008, respectively). After adjustment for obesity-correlated variables, multiple linear regression analysis showed that EFT remained the best correlate of SIRT1 (β = -0.352, P = 0.016). CONCLUSIONS Circulating SIRT1 correlates with the visceral fat content of the heart. Serum SIRT1 levels might provide additional information for risk assessment of coronary artery disease in patients with obesity.
Collapse
Affiliation(s)
- S Mariani
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy.
| | - D Costantini
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - C Lubrano
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - S Basciani
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - C Caldaroni
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - G Barbaro
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - E Poggiogalle
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - L M Donini
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - A Lenzi
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| | - L Gnessi
- Department of Experimental Medicine, Section of Medical Physiopathology, Food Science and Endocrinology, "Sapienza" University of Rome, 00161 Rome, Italy
| |
Collapse
|
6
|
Costantini D, Gustin M, Ferrarini A, Dell'Omo G. Estimates of avian collision with power lines and carcass disappearance across differing environments. Anim Conserv 2016. [DOI: 10.1111/acv.12303] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- D. Costantini
- Department of Biology; University of Antwerp; Wilrijk Belgium
- Institute for Biodiversity; Animal Health and Comparative Medicine; University of Glasgow; Glasgow UK
| | - M. Gustin
- Conservation Department; Lipu - BirdLife International; Parma Italy
| | - A. Ferrarini
- Conservation Department; Lipu - BirdLife International; Parma Italy
| | | |
Collapse
|
7
|
Einor D, Bonisoli-Alquati A, Costantini D, Mousseau TA, Møller AP. Ionizing radiation, antioxidant response and oxidative damage: A meta-analysis. Sci Total Environ 2016; 548-549:463-471. [PMID: 26851726 DOI: 10.1016/j.scitotenv.2016.01.027] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2015] [Revised: 01/06/2016] [Accepted: 01/06/2016] [Indexed: 05/22/2023]
Abstract
One mechanism proposed as a link between exposure to ionizing radiation and detrimental effects on organisms is oxidative damage. To test this hypothesis, we surveyed the scientific literature on the effects of chronic low-dose ionizing radiation (LDIR) on antioxidant responses and oxidative damage. We found 40 publications and 212 effect sizes for antioxidant responses and 288 effect sizes for effects of oxidative damage. We performed a meta-analysis of signed and unsigned effect sizes. We found large unsigned effects for both categories (0.918 for oxidative damage; 0.973 for antioxidant response). Mean signed effect size weighted by sample size was 0.276 for oxidative damage and -0.350 for antioxidant defenses, with significant heterogeneity among effects for both categories, implying that ionizing radiation caused small to intermediate increases in oxidative damage and small to intermediate decreases in antioxidant defenses. Our estimates are robust, as shown by very high fail-safe numbers. Species, biological matrix (tissue, blood, sperm) and age predicted the magnitude of effects for oxidative damage as well as antioxidant response. Meta-regression models showed that effect sizes for oxidative damage varied among species and age classes, while effect sizes for antioxidant responses varied among species and biological matrices. Our results are consistent with the description of mechanisms underlying pathological effects of chronic exposure to LDIR. Our results also highlight the importance of resistance to oxidative stress as one possible mechanism associated with variation in species responses to LDIR-contaminated areas.
Collapse
Affiliation(s)
- D Einor
- Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA.
| | - A Bonisoli-Alquati
- Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA; School of Renewable Natural Resources, Louisiana State University AgCenter, Baton Rouge, LA 70803, USA.
| | - D Costantini
- Department of Biology, University of Antwerp, Wilrijk, B-2610, Antwerp, Belgium.
| | - T A Mousseau
- Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA; Faculty of Bioscience and Biotechnology, Chubu University, Kasugai, Japan.
| | - A P Møller
- Laboratoire d'Ecologie, Systématique et Evolution, CNRS UMR 8079, Université Paris-Sud, Bâtiment 362, F-91405 Orsay Cedex, France.
| |
Collapse
|
8
|
Lubrano C, Masieri S, Costantini D, Francomano D, Watanabe M, Mariani S, Basciani S, Donini LM, Lenzi A, Gnessi L. Nickel sensitivity in Italian overweight-obese patients. Eur J Public Health 2015. [DOI: 10.1093/eurpub/ckv175.253] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Greusard L, Costantini D, Bousseksou A, Decobert J, Lelarge F, Duan GH, De Wilde Y, Colombelli R. Near-field analysis of metallic DFB lasers at telecom wavelengths. Opt Express 2013; 21:10422-10429. [PMID: 23669898 DOI: 10.1364/oe.21.010422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
We image in near-field the transverse modes of semiconductor distributed feedback (DFB) lasers operating at λ ≈ 1.3 μm and employing metallic gratings. The active region is based on tensile-strained InGaAlAs quantum wells emitting transverse magnetic polarized light and is coupled via an extremely thin cladding to a nano-patterned gold grating integrated on the device surface. Single mode emission is achieved, which tunes with the grating periodicity. The near-field measurements confirm laser operation on the fundamental transverse mode. Furthermore--together with a laser threshold reduction observed in the DFB lasers--it suggests that the patterning of the top metal contact can be a strategy to reduce the high plasmonic losses in this kind of systems.
Collapse
Affiliation(s)
- L Greusard
- Institut Langevin, CNRS UMR7587, 1, rue Jussieu, 75005 Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Valenza F, Rosso L, Gatti S, Coppola S, Froio S, Colombo J, Dossi R, Pizzocri M, Salice V, Nosotti M, Reggiani P, Tosi D, Palleschi A, Pappalettera M, Ferrero S, Perazzoli A, Costantini D, Scalamogna M, Rossi G, Colombo C, Santambrogio L, Gattinoni L. Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation. Transplant Proc 2013; 44:1826-9. [PMID: 22974847 DOI: 10.1016/j.transproceed.2012.06.023] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Ex vivo lung perfusion (EVLP) has been validated as a valuable technique to increase the pool of organs available for lung transplantation. MATERIAL AND METHODS After a preclinical experience, we obtained permission from the Ethics Committee of our institution to transplant lungs after EVLP reconditioning. ABO compatibility, size match, and donor arterial oxygen pressure (PaO(2))/fraction of inspired oxygen (FiO(2)) ≤ 300 mm Hg were considered to be inclusion criteria, whereas the presence of chest trauma and lung contusion, evidence of gastric content aspiration, pneumonia, sepsis, or systemic disease were exclusion criteria. We only considered subjects on an extra corporeal membrane oxygenation (ECMO) bridge to transplantation with rapid functional deterioration. Using Steen solution with packed red blood cells oxygenated with 21% O(2), 5% to 7% CO(2) was delivered, targeted with a blood flow of approximately 40% predicted cardiac output. Once normothermic, the lungs were ventilated with a tidal volume of 7 mL/kg a PEEP of 5 cmH(2)O and a respiratory rate of 7 bpm. Lungs were considered to be suitable for transplantation if well oxygenated [P(v-a) O(2) > 350 mm Hg on FiO(2) 100%], in the absence of deterioration of pulmonary vascular resistance and lung mechanics over the perfusion time. RESULTS From March to September 2011, six lung transplantations were performed, including two with EVLP. The functional outcomes were similar between groups: at T72 posttransplantation, the median PaO(2)/FiO(2) were 306 mm Hg (range, 282 to 331 mm Hg) and 323 mm Hg (range, 270 to 396 mm Hg) (P = 1, EVLP versus conventional). Intensive care unit ICU and hospital length of stay were similar (P = .533 and P = .663, respectively) with no mortality at 60 days in both groups. EVLP donors were older (49 ± 6 y versus 21 ± 7 y, P < .05), less well oxygenated (184 ± 6 mm Hg versus 570 ± 30, P < .05), displaying higher Oto scores (9.5 ± 0.7 versus 1.7 ± 1.5, P < .05). CONCLUSIONS The first 6 months of the EVLP program allowed us to increase the number of organs available for transplantation with short-term outcomes comparable to conventional transplantations.
Collapse
Affiliation(s)
- F Valenza
- Dipartimento di Anestesia, Terapia Intensiva e Subintensiva e Terapia del Dolore, Università degli Studi di Milano, Milano, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Costantini D, Walker M, Milligan N, Keating S, Kingdom J. Pathologic basis of improving the screening utility of 2-dimensional placental morphology ultrasound. Placenta 2012; 33:845-9. [DOI: 10.1016/j.placenta.2012.07.010] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2012] [Revised: 06/22/2012] [Accepted: 07/13/2012] [Indexed: 01/05/2023]
|
12
|
Costantini D, Greusard L, Bousseksou A, Rungsawang R, Zhang TP, Callard S, Decobert J, Lelarge F, Duan GH, De Wilde Y, Colombelli R. In situ generation of surface plasmon polaritons using a near-infrared laser diode. Nano Lett 2012; 12:4693-4697. [PMID: 22924784 DOI: 10.1021/nl302040e] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
We demonstrate a semiconductor laser-based approach which enables plasmonic active devices in the telecom wavelength range. We show that optimized laser structures based on tensile-strained InGaAlAs quantum wells-coupled to integrated metallic patternings-enable surface plasmon generation in an electrically driven compact device. Experimental evidence of surface plasmon generation is obtained with the slit-doublet experiment in the near-field, using near-field scanning optical microscopy measurements.
Collapse
Affiliation(s)
- D Costantini
- Institut d'Electronique Fondamentale, Univ. Paris Sud, CNRS UMR8622, 91405 Orsay, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Tetienne JP, Bousseksou A, Costantini D, De Wilde Y, Colombelli R. Design of an integrated coupler for the electrical generation of surface plasmon polaritons. Opt Express 2011; 19:18155-18163. [PMID: 21935181 DOI: 10.1364/oe.19.018155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Recently a surface plasmon polariton (SPP) source based on an electrically operated semiconductor laser has been demonstrated. Here we present a numerical investigation of the light-SPP coupling process involved in the device. The problem consists in the coupling via a diffraction grating between a dielectric waveguide mode--the laser mode--and a SPP mode. The issue of the coupling efficiency is discussed, and the dependence on various geometrical parameters of both the grating and the dielectric waveguide is studied in detail. A maximum coupling efficiency of ≈24% is obtained at telecom wavelengths, which could lead to a high-power integrated SPP source when combined to a laser medium.
Collapse
Affiliation(s)
- J-P Tetienne
- Institut d'Electronique Fondamentale, Université Paris Sud and CNRS, UMR8622, Orsay, France
| | | | | | | | | |
Collapse
|
14
|
Casagrande S, Dell'omo G, Costantini D, Tagliavini J, Groothuis T. Variation of a carotenoid-based trait in relation to oxidative stress and endocrine status during the breeding season in the Eurasian kestrel: a multi-factorial study. Comp Biochem Physiol A Mol Integr Physiol 2011; 160:16-26. [PMID: 21620990 DOI: 10.1016/j.cbpa.2011.04.011] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2011] [Revised: 04/20/2011] [Accepted: 04/25/2011] [Indexed: 02/06/2023]
Abstract
Carotenoid-based skin colorations vary seasonally in many bird species and are thought to be honest sexually selected signals. In order to provide more insight in the potential signal function and underlying mechanisms of such colorations we here quantified patterns of variation of leg coloration in adult male and female Eurasian kestrels (Falco tinnunculus tinnunculus) over the breeding season, and evaluated the relationship between coloration and levels of carotenoids, androgens and estrogens, oxidative damage and plasma non-enzymatic antioxidant capacity. We studied both reproducing wild and non-reproducing captive birds to test for the effect of diet and breeding effort. Males were more colored than females only during mating, and independently of diet, suggesting that leg-color is a sexually selected trait. Seasonal variation in leg color was associated with circulating carotenoids, but concentrations of these molecules were not related to antioxidant capacity, body condition or oxidative damage. These results indicate that carotenoid-based colorations may not be an honest signal of health status in this species. Production of carotenoid rich eggs coincided with low levels of circulating carotenoids in females, indicating that carotenoids might be a limited resource for laying female kestrels. Finally, young rearing males had higher levels of oxidative damage than females, and wild birds of both sexes had higher levels of these parameters than captive birds. These results may indicate that parental effort and physical activity are costly, independently from hormonal status. Since androgens did not explain carotenoid variation we suggest that multiple interacting factors can regulate carotenoid levels along the season.
Collapse
Affiliation(s)
- S Casagrande
- Behavioral Biology, Institute for Behavior and Neuroscience, University of Groningen, P.O. Box 14 9750 AA, Haren, The Netherlands.
| | | | | | | | | |
Collapse
|
15
|
Nosotti M, Rosso L, Palleschi A, Lissoni A, Crotti S, Marenghi C, Colombo C, Costantini D, Santambrogio L. Bridge to lung transplantation by venovenous extracorporeal membrane oxygenation: a lesson learned on the first four cases. Transplant Proc 2010; 42:1259-61. [PMID: 20534275 DOI: 10.1016/j.transproceed.2010.03.119] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Extracorporeal membrane oxygenation (ECMO) is the only therapeutic option for patients with ventilation-refractory hypercapnia while awaiting lung transplantation. Moreover, there is increasing success using ECMO for definitive respiratory failure in formerly healthy patients. This report describes the use of membrane oxygenation as a bridge to lung transplantation in 2 patients on the waiting list and in 2 previously healthy patients. Our experience showed that coagulation management, critical illness myopathy, and psychological disorders were the most critical problems. One patient died at 2 days after transplantation, 1 at 3 months, and 2 returned to their pretransplantation activities. We concluded that ECMO is an adequate bridge to lung transplantation but, especially in formerly healthy patients, an awake procedure is advisable for a successful outcome.
Collapse
Affiliation(s)
- M Nosotti
- Thoracic Surgery and Lung Transplantation Unit, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Claut L, Costantini D, Faelli N, Motta V, Costantino L, Colombo C. CFTR-related disease: clinical characterization and long term follow up. J Cyst Fibros 2010. [DOI: 10.1016/s1569-1993(10)60037-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
17
|
Faelli N, Tirelli A, Costantini D, Biffi A, Motta V, Conese M, Colombo C. Cytokine profiles in different matrices before and after therapy for acute exacerbation in cystic fibrosis (CF) patients. J Cyst Fibros 2010. [DOI: 10.1016/s1569-1993(10)60194-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
18
|
Costantini D, Carello L, Dell'Omo G. Patterns of covariation among weather conditions, winter North Atlantic Oscillation index and reproductive traits in Mediterranean kestrels. J Zool (1987) 2010. [DOI: 10.1111/j.1469-7998.2009.00649.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Costantini D, Lipp HP. Short restraint time does not influence markers of serum oxidative stress in homing pigeons (Columba livia). J Anim Physiol Anim Nutr (Berl) 2010; 94:24-8. [DOI: 10.1111/j.1439-0396.2008.00880.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
20
|
Cariani L, Defilippi G, Costantini D, Colombo C, Garlaschi M, Torresani E, Biffi A. Antibiotics sensitivity in mucoid and non mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Cyst Fibros 2009. [DOI: 10.1016/s1569-1993(09)60162-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Di Cicco M, Ferrario F, Costantini D, Colombo C. SPHENOID SINUS MUCOCELE IN A CYSTIC FIBROSIS CHILD. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60563-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
22
|
Battezzati A, Battezzati P, Costantini D, Zazzeron L, Russo M, Daccò V, Motta V, Colombo C. CYSTIC FIBROSIS RELATED DIABETES IS ANTICIPATED BY REDUCED INSULIN SECRETION DURING OGTT. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60554-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
23
|
Costantini D, Biffi A, Garlaschi M, Zazzeron L, Clarizia G, Colombo C, Cariani L. ACHROMOBACTER XYLOSOXIDANS: FOLLOW-UP OF 20 PATIENTS WITH CHRONIC INFECTION. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60551-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
24
|
Colombo C, Faelli N, Tirelli A, Conese M, Costantini D, Biffi A, Motta V. CYTOKINE PROFILES IN DIFFERENT MATRIXES (SERUM, SPUTUM AND EXHALATE) OF CYSTIC FIBROSIS PATIENTS. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60553-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
25
|
Biffi A, Costantini D, Colombo C, Zazzeron L, Garlaschi M, Torresani E, Cariani L. Diagnostic value of antibody anti Pseudomonas aeruginosa in early lung infection in cystic fibrosis patients. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60126-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
|
27
|
Paracchini V, Seia M, Coviello D, Porcaro L, Costantino L, Capasso P, Degiorgio D, Padoan R, Corbetta C, Claut L, Costantini D, Colombo C. Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions. Clin Genet 2008; 73:346-52. [PMID: 18279436 DOI: 10.1111/j.1399-0004.2007.00957.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Cystic fibrosis (CF) is mainly caused by small deletions or missense mutations in the CFTR gene. The CF mutation database lists more than 35 large rearrangements that may escape detection using polymerase chain reaction-base techniques. The Innogenetics assay, the denaturing high-performance liquid chromatography and sequencing screening showed a mutation detection rate of 92.6% in our population. We report here the results of multiplex ligation-dependent probe amplification (MLPA) screening for CFTR gene rearrangements, performed on the unidentified alleles of our CF patients. Our sample population consists of 692 non-related Italian CF patients (for a total of 1384 alleles), followed at CF Centres in the Lombardia Region. MLPA analysis was performed in 49 patients who still had one or two unidentified alleles (for a total of 52 unidentified alleles) after extensive analysis of CFTR gene. All patients who were studied had the classical form of CF. We characterized nine different deletions and a new duplication. The deletion of exons 22-23 (7/82) was the most frequent in our cohort. The search for deletion/duplications of the CFTR gene has made it possible to reach a 94.1% detection rate, with an improvement (1.6%) of the carrier detection rate in the Italian population.
Collapse
Affiliation(s)
- V Paracchini
- Medical Genetics Laboratory, Fondazione IRCCS Policlinico, Mangiagalli, Regina Elena, Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
|
29
|
Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Daccò V, Bertoli S, Crosignani A, Colombo C. Spontaneous hypoglycemia in patients with cystic fibrosis. Eur J Endocrinol 2007; 156:369-76. [PMID: 17322497 DOI: 10.1530/eje.1.02344] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Diabetes frequently complicates cystic fibrosis (CF) without fasting hyperglycemia or despite spontaneous hypoglycemia (anecdotally ascribed to malnutrition), whose prevalence, clinical meaning, and relationship with glucose tolerance and clinical/nutritional status were not previously investigated. The relationship of CF genotype with insulin secretion control is also unclear. DESIGN AND METHODS A total of 129 CF patients without stable diabetes received 188 oral glucose tolerance tests. Distribution of fasting plasma glucose (FPG), glucose, insulin and C-peptide responses, clinical/nutritional variables, and their relationships were analyzed. RESULTS FPG < 60 mg/dl (3.3 mmo/l) was detected in 14% of studies and reactive hypoglycemia (PG < 50 mg/dl (2.8 mmo/l)) in 15%. OGTT-based diabetes frequency was similar in the lowest quartile (Q1) and Q2-3 for FPG (10 and 8%), with higher glucose increment and area under the curve in Q1. Insulin and C-peptide levels were similar among FPG quartiles. Class I cystic fibrosis transmembrane conductance regulator mutation carriers had higher insulin concentrations than class II, especially in Q1 for FPG. Age, sex, nutritional, and anthropometric parameters including fat and lean body mass were unrelated to FPG. Lower FPG was associated with more frequent hospitalization rates (P = 0.002) and lower Shwachman scores (P = 0.041). Steroids weaning was accurately evaluated but then excluded as a possible cause of hypoglycemia. CONCLUSIONS/INTERPRETATION Fasting asymptomatic hypoglycemia is frequent and possibly related to inappropriate insulin secretion control in class I mutation carriers. Low FPG does not exclude impaired glucose tolerance (IGT) and diabetes in CF and reflects worse clinical status.
Collapse
Affiliation(s)
- A Battezzati
- Department of Pediatrics, CF Center, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Colombo C, Costantini D, Russo MC, Claut L, Porcaro L, Nobili R. Is early identification of asymptomatic infants with 'mild' CFTR genotypes clinically useful? Acta Paediatr 2007; 96:477-9. [PMID: 17407489 DOI: 10.1111/j.1651-2227.2007.00142.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Esposito S, Colombo C, Ravaglia R, Faelli N, Tagliabue C, Corti F, Costantini D, Principi N. Mycoplasma pneumoniae Pericarditis and Cardiac Tamponade in a 7-Year-Old Girl with Cystic Fibrosis. Infection 2006; 34:355-6. [PMID: 17180594 DOI: 10.1007/s15010-006-6628-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2006] [Accepted: 08/09/2006] [Indexed: 11/24/2022]
|
32
|
Garlaschi M, Cariani L, Marchi M, Costantini D, Colombo C, Clarizia G, Laricchia L, Russo M, Torresani E. METODO COLTURALE PER L’ISOLAMENTO DI MYCOBACTERIUM ABSCESSUS E MYCOBACTERIUM CHELONAE DALL’ ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA. Microbiol Med 2006. [DOI: 10.4081/mm.2006.3142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
33
|
Merle P, Si Ahmed S, Habersetzer F, Abergel A, Taieb J, Bonyhay L, Costantini D, Dufour-Lamartinie J, Trepo C. Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug (DT) for patients with advanced hepatocellular carcinoma (HCC). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.14094] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
14094 Background: HCC is a highly chemoresistant due to MDR efflux pumps. DT is a newly cytotoxic chemotherapy composed of doxorubicin-loadded polyisohexylcyanoacrylate nanoparticles, allowing doxorubicin to overcome MDR pumps [Barraud, J Hepatol 2005; 42: 736]. Methods: 16 cirrhotic patients (pts) of Child-Pugh A with advanced HCC, transaminases/GGT <5N, platelets >100000/mm3, neutrophiles >1500/mm3, were enrolled in a multicentric noncontrolled study. A single IAH injection of 10, 20, 30, 35, or 40mg/m2 DT (respectively 3,3,4, and 3 pts) was performed, tolerance and efficacy being assessed 4 weeks later. Results: Grade 4 neutropenia (2pts at 40mg/m2) gave the Maximal Tolerated Dose. Grade 2–3 hypertransaminasemia (transient) occurred dose-independently. Two serious adverse events (SAE) were hypotension and acute respiratory distress syndrome. All adverse events (AE) (90% grade 1–2) occurring during injection were dose-independent, and completely and fastly recovered : cough (6pts), dyspnea (2pts), SaO2 decrease (2pts), tachycardia (2pts), bradycardia (2pts), hypotension (2pts). Anti-tumor efficacy of DT was evaluated by helicoidal CT-scan with contrast injection 4 weeks after injection : 3pts (20%) showed partial response with frank decrease of contrast enhancement at arterial perfusion, 8pts (50%) remained stable, and 5pts (30%) had progression. Conclusions: This phase 1 showed that a single IAH injection of DT was safe until 35 mg/m2 for Child-Pugh A patients with advanced HCC. This dosage will be retained for the phase 2 step comprising 3 injections at 4-week intervals which will aim at confirming the antitumour efficacy of DT for HCC. [Table: see text]
Collapse
Affiliation(s)
- P. Merle
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - S. Si Ahmed
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - F. Habersetzer
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - A. Abergel
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - J. Taieb
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - L. Bonyhay
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - D. Costantini
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - J. Dufour-Lamartinie
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| | - C. Trepo
- CHU de Lyon, Lyon, France; Centre Hospitalier Régional d’Orléans, Orleans, France; Hôpitaux Civils de Strasbourg, Strasbourg, France; CHU de Clermont-Ferrand, Clermont-Ferrand, France; Hôpital de la Pitié Salpétrière, Paris, France; Bioalliance Pharma, Paris, France
| |
Collapse
|
34
|
Merle P, Si Ahmed S, Habersetzer F, Abergel A, Taieb J, Bonyhay L, Costantini D, Dufour-Lamartinie J, Trépo C. P.384 Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug® (DT) for patients with advanced hepatocellular carcinoma (HCC). J Clin Virol 2006. [DOI: 10.1016/s1386-6532(06)80558-5] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
35
|
Garlaschi M, Cariani L, Laricchia L, Clarizia G, Russo P, Costantini D, Galbiati S, Blasi F, Torresani E. INDIVIDUAZIONE PRECOCE DI PSEUDOMONAS AERUGINOSA NELL’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA MEDIANTE PCR. Microbiol Med 2005. [DOI: 10.4081/mm.2005.3690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
36
|
Cardot JM, Chaumont C, Dubray C, Costantini D, Aiache JM. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. Br J Clin Pharmacol 2004; 58:345-51. [PMID: 15373926 PMCID: PMC1884608 DOI: 10.1111/j.1365-2125.2004.02154.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2003] [Accepted: 03/24/2004] [Indexed: 11/28/2022] Open
Abstract
AIMS The aim of this study was to compare salivary miconazole pharmacokinetics following once daily application of bioadhesive tablets (50 or 100 mg), vs the current treatment with a gel (3 times a day, 375 mg day(-1)). METHODS A three way cross over study was carried out in 18 healthy subjects (nine males, nine females) with a 1 week washout period between each treatment. Plasma and salivary pharmacokinetics of miconazole were assessed over a 24-h period. RESULTS In all subjects the tablets gave higher and more prolonged salivary miconazole concentrations than the gel. Thus salivary miconazole AUC(0,24 h) was 37.2 times greater for the 100 mg tablet (90% confidence interval [CI] 22.9, 60.5) and 18.9 times greater for the 50 mg tablet (CI 11.7, 30.6) compared with the gel. Similarly, Cmax was 17.2 times greater (CI 11.8, 25.2) and 7.8 times greater (CI 5.3, 11.4) for the 100 mg tablet and 50 mg tablet, respectively. Comparison of the 100 mg and 50 mg tablets gave ratios of 2.2 and 2.0 for Cmax and AUC(0,24 h), respectively (CI 1.5, 3.2 and 1.2, 3.2). The mean time that salivary miconazole concentrations were above 0.4 micro g ml(-1) (the concentration reached 3 h after application of the oral gel according to published data) or above 1.0 microg ml(-1) (the MIC of some Candida species) was greater for both bioadhesive tablets than for the oral gel (10-14 h vs 1.5 h and 7 h vs 0.6 h). Only 19 plasma samples from eight subjects had concentrations of miconazole above 0.4 micro g ml(-1). Ten of these were taken from five subjects after administration of the gel and nine from three subjects after administration of the tablets. CONCLUSIONS These data strongly support the further development of miconazole bioadhesive tablets as a sustained release formulation leading to improved antifungal exposure in the buccal cavity. A single daily application should improve compliance, whereas the low systemic absorption of miconazole will alleviate concerns regarding drug interactions and adverse effects.
Collapse
Affiliation(s)
- J-M Cardot
- Laboratoire de Biopharmacie, Faculté de Pharmacie, 28 Place Henri Dunant, BP 38, F 63001 Clermont-Ferrand, France.
| | | | | | | | | |
Collapse
|
37
|
Garlaschi M, Cariani L, Scarazatti M, Clarizia G, Russo P, Laricchia L, Costantini D. TREND DELLA SENSIBILITÀ DI BATTERI NON FERMENTANTI ISOLATI DALL’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA (2001-2003). Microbiol Med 2004. [DOI: 10.4081/mm.2004.3859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
38
|
Garlaschi M, Cariani L, Scarazatti M, Clarizia G, Russo P, Laricchia L, Costantini D. DETERMINAZIONE DEL LIVELLO SIERICO DI ANTICORPI ANTIPSEUDOMONAS AERUGINOSA IN PAZIENTI CON FIBROSI CISTICA. Microbiol Med 2004. [DOI: 10.4081/mm.2004.3862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
39
|
De Capua B, De Felice C, Costantini D, Bagnoli F, Passali D. Newborn hearing screening by transient evoked otoacoustic emissions: analysis of response as a function of risk factors. Acta Otorhinolaryngol Ital 2003; 23:16-20. [PMID: 12812130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
Hearing loss can be considered as the most common birth defect. Early detection of hearing loss by screening at, or shortly after, birth and appropriate intervention are critical to speech, language and cognitive development. In the present study, the characteristics of Transient Evoked Otoacoustic Emissions have been evaluated as a function of known pre- and perinatal risk factors for hearing loss. All newborns were screened for hearing loss using a physiologic test of hearing function, the Transient Evoked Otoacoustic Emissions. A total of 532 consecutive newborn infants received binaural Transient Evoked Otoacoustic Emission testing (262 males, 270 females; mean gestational age 39.2 +/- 2.1 weeks, range 26-43; birth weight: 3,240 +/- 550 g, range 910-4,780). The population examined comprised 448 control infants and 84 high-risk for hearing loss infants (Joint Committee on Infant Hearing 1994 criteria). All Transient Evoked Otoacoustic Emission recordings were performed at comparable postconceptional ages. Audiological screening by Transient Evoked Otoacoustic Emission recording showed an overall 100% sensitivity, 99.02% specificity, with negative and positive predictive values of 100% and 62.5%, respectively. As compared to controls, high-risk infants showed: 1. increased rates of Fail-1 (Transient Evoked Otoacoustic Emissions absent at first examination, 21.4% vs 9.8%, p = 0.004), Fail-2 (Transient Evoked Otoacoustic Emissions absent on retesting: 8.64% vs 1.37%, p = 0.0014), false positives (Transient Evoked Otoacoustic Emissions absent/V wave present: 3.7% vs 0.46%, p = 0.029) and true positives (Transient Evoked Otoacoustic Emissions absent, V wave absent: 2.47% or 24.5 per 1,000 live births vs 0.22% or 2.2 per 1,000 live births, p = 0.013); 2. significantly reduced Transient Evoked Otoacoustic Emission intensity in the 0.7-1 kHz (right side) and 1-2 kHz (left side) frequency ranges. Multivariate logistic regression analysis showed a significant positive correlation between congenital hearing loss and the following risk factors: assisted ventilation lasting > 10 days (Odds ratio 14.8; 95% confidence interval, 4.5-48.8, p < 0.000001), severe birth asphyxia (Odds ratio 5.8; 95% confidence interval; 2.1-16.1; p = 0.0006) and administration of ototoxic drugs (Odds ratio 4.5; 95% confidence interval; 1.4-13.9; p = 0.009). Results of this study confirm the feasibility and accuracy of universal neonatal hearing screening based on recording Transient Evoked Otoacoustic Emissions. These data stress the importance of the risk factors for hearing loss, including prolonged assisted ventilation, ototoxic drugs, and severe birth asphyxia.
Collapse
Affiliation(s)
- B De Capua
- Department of Otorhinolaryngology, University of Siena, Italy.
| | | | | | | | | |
Collapse
|
40
|
Padoan R, Costantini D, Russo MC, Ambrosioni A, Fiori S, Prandoni S, Cantù-Rajnoldi A, Seia M, Giunta A. A novel missense mutation (Y89C) in exon 3 of the CFTR (ABCC7) gene in a young male. Hum Mutat 2000; 15:486. [PMID: 10790225 DOI: 10.1002/(sici)1098-1004(200005)15:5<486::aid-humu25>3.0.co;2-s] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- R Padoan
- Centro di Riferimento Regionale per la Fibrosi Cistica, Università degli Studi, Milano
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Nys V, Terrier JL, Certain B, Costantini D. [Application of good clinical practices. An example of organization]. Ann Pharm Fr 1999; 57:468-75. [PMID: 10605153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
The quality of clinical trials is guaranteed by good clinical practices (GCP). An evaluation of data and patient safety is evaluated for each procedure making up GCP. Compliance to GCP is required for clinical trials performed in France to gain international recognition. Several pharmaceutical firms have modified their trial procedures in order to assure application of GCP. Key posts for monitors and clinical research assistants have been created. They play a major role in following up clinical trials and control the application of pre-established standardized procedure. Follow-up documents provide written proof of how GPC were applied and also add credibility to the trial during an audit or inspection. In the hospital setting, clinics, research centres, pharmaceutical units, and dispensaries are also largely implicated in the quality of the trial. Each must have adequate means of applying GCP with the aim of improving the signification of medical observation during therapeutic trials.
Collapse
Affiliation(s)
- V Nys
- Hôpitaux de Paris, Nanterre
| | | | | | | |
Collapse
|
42
|
Delogu G, Lo Bosco L, Ciccioli T, Amati F, Suhayda C, Costantini D, Signore L. TNF alpha released in the early post-operative period is influenced by anaesthesia. Ann Ital Chir 1998; 69:15-20. [PMID: 11995034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
In this study we tested for TNF alpha concentrations 45 subjects undergoing elective prostatectomy performed under two different anaesthetic regimens. In addition, given the influence of neuroendocrine axis on immunological homeostasis, we also determined post surgery cortisol and norepinephrine levels. The patients were randomly assigned to one of two groups: group 1 (no. = 24) received NLA general anaesthesia, whereas group 2 (no. = 21) received spinal analgesia. Blood samples were drawn the day before surgery (t0), at two (t1), at 24 (t2), at 48 (t3) and 72 (t4) hours from the completion of operation. In the patients assigned to the general anaesthesia group an increase of circulating TNF alpha was detected through t1 to t4. In the spinal group TNFa values did not change in t1 and t2, whereas enhanced levels of the cytokine--overlapping with those of group 1--were observed at 48 and 72 hrs following surgery. Cortisol response increased in both the groups, peaking at t1 but, at this time patients undergoing spinal anaesthesia were found to have significantly lower circulating cortisol. A rise of plasma norepinephrine was observed at t1 in the general anaesthesia group alone. For the early TNF alpha increase, observed in group 1 only, we hypothesize that anaesthetics, such as NLA agents, may trigger a TNF alpha release in vivo. Alternatively TNF alpha production may represent the result of the neuroendocrine response such as cortisol and norepinephrine, to the surgical/anaesthetic trauma which could be blocked by subarachnoid anaesthesia. Conversely, the late TNF alpha increase found in all the patients studied might be explained by postoperative infections as well as by inflammation of the injured tissues and/or normal wound healing.
Collapse
Affiliation(s)
- G Delogu
- Istituto di Anestesiologia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | | | |
Collapse
|
43
|
Costantini D, Delogu G, Lo Bosco L, Tomasello C, Sarra M. The treatment of cranio-facial pain by electroacupuncture and laser irradiation. Ann Ital Chir 1997; 68:505-9. [PMID: 9494181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Craniofacial neuralgias represent an interesting medical challenge, especially regarding the complex therapeutical aspects. Our study was performed treating more than 700 patients, applying steel inox needles variable in diameters and length for about 20 minutes, with a total application number ranging between 10 and 20. Results have been defined referring to a 4-grades response scale: excellent, good, fairly good and insufficient. It is important to emphasise that the best results have been achieved with patients who chose the acupuncture as the first therapeutic approach, while patients who underwent other previous medical and/or surgical treatment have had a worse response. The authors assert that acupuncture and infrared laser reflex therapy represent a harmless and effective treatment of such a diffuse and invalidating disease.
Collapse
Affiliation(s)
- D Costantini
- Istituto di Anestesiologia e Rianimazione Università degli Studi di Roma La Sapienza
| | | | | | | | | |
Collapse
|
44
|
Delogu G, Iona E, Amati F, Marandola M, Costantini D, Baumgartner IM, Mascellino MT. ["Killing" of pseudomonas aeruginosa isolated from patients with critical post-operative complications. Effect of various antibiotics]. Ann Ital Chir 1997; 68:219-24. [PMID: 9290013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We undertook this study to estimate phagocytic killing by neutrophils (PMNs) of Pseudomonas aeruginosa pre-exposed to sub-inhibitory concentration of Amikacin and Imipenem. In particular, we have isolated bacteria from endotracheal aspirates of post-operative patients mechanically ventilated admitted to an ICU with respiratory failure. PMNs were obtained both from these patients (Group A, n. 6) as well as from subjects submitted to surgery with uncomplicated post-operative period (Group B, n. 8). From specimens tested, 6 strains of Pseudomonas aeruginosa were isolated. Results showed that the rate of killing of bacteria treated with Amikacin was no different from that of untreated bacteria, whichever the source of PMNs, either from Group A or Group B patients. On the other hand, the microbicidal effect on P. aeruginosa exposed to Imipenem was significantly enhanced when PMNs were obtained from Group B patients. In the mixture bacteria, Imipenem and PMNs obtained from Group A the rate of killing was low, similar to the controls without antibiotics. Such a finding suggests a possible impairment of PMNs due to the critical disease and in some way responsible for the host adverse interaction between granulocytes, antibiotics and pathogens. The underlying mechanisms remain to be clarified and further studies are required to understand the possible clinical implications.
Collapse
Affiliation(s)
- G Delogu
- Istituto di Anestesia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | | | |
Collapse
|
45
|
Delogu G, Tomasello C, Vellante L, Ruberto FG, Urbano V, Costantini D, Signore L. [Effects on ventilation secondary to laparoscopic and laparotomic cholecystectomy]. Ann Ital Chir 1997; 68:81-5. [PMID: 9235869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE Evaluation of respiratory function after 24 hours from intervention related to two different surgical techniques of cholecistectomy. PATIENTS AND METHODS Thirty patients submitted to cholecystectomy, nine by laparotomy and twenty-one by video-laparoscopy. The ventilatory parameters considered are as follows: CV, FCV, VEF1, FEF25-75%; and moreover also some variables of acid-base balance: pH, paCO2 e paO. RESULTS In all cases was evidenced a decrease of respiratory activity. This phenomenon was more evident in the laparotomy group (CV = 37, 35, FCV = 41, 47, VEF1 = 40, FEF25-75% = 36.62% related to preoperative values versus 71.20, 80.88, 79.29, 77.91% in the videolaparoscopic group. No significative differences were registered between the two groups as to postoperative paO2, which was moderately lower in all patients, while no variation was observed for pH and paCO2. CONCLUSIONS Data collected confirm that after laparoscopic cholecystectomy the ventilatory respiratory capacity is better conserved, that clinically means lower incidence of postoperatory pulmonary complications.
Collapse
Affiliation(s)
- G Delogu
- Istituto di Anestesia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | | | |
Collapse
|
46
|
Delogu G, Marano M, Marandola M, Ciccioli T, Lombardi A, Costantini D. [Thoracoscopic bilateral sympathectomy in Raynaud's syndrome. Anesthesiology problems]. Ann Ital Chir 1996; 67:405-8; discussion 409. [PMID: 9019993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The objective of this paper was to examine the major anaesthetic problems during transthoracic endoscopic sympathectomy without artificial pneumothorax and to present our experience of 16 cases suffering from Raynaud's disease. For the perioperative management we used a double lumen endo-bronchial tube and balanced anaesthesia (intravenous agents plus isoflurane). Arterial pressure, heart rate, ECG, end-tidal carbon dioxide concentration, SatO2, blood gases and peak inspiratory pressures were monitored. The results showed that no significant changes in these parameters occurred during surgery. Since hypoxaemia is the main problem of the thoracoscopic sympathectomy the A.A. emphasize the necessity to ensure a correct ventilation as well as a haemodynamic stability throughout the procedure. The combination of balanced anaesthesia and double lumen endobronchial intubation seems an advisable method when no artificial pnx is instituted. A close monitoring of the circulatory and respiratory systems is imperative.
Collapse
Affiliation(s)
- G Delogu
- Istituto di Anestesia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | |
Collapse
|
47
|
Testa G, Borzomati V, Costantini D, De Chiara A, Picarazzi A, Capelli O. [Use of new elastomeric pumps and PCA in postoperative pain control in thoraco-abdominal surgery]. Ann Ital Chir 1996; 67:257-63. [PMID: 8929043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
36 patients submitted to interventions for thoraco-abdominal surgery has been submitted to antalgic post-operatory therapy with elastomeric pump at a continuous intravenous infusion and patient controlled analgesia (PCA). The patients have been randomized in three groups. The patients of the 1 degree group received 30 minutes before of the end of the surgical intervention 30 mg of Ketorolac. At the end of the anesthesia came started an infusion of 150 mg of Ketorolac (5 vials) in 60 ml of isotonic chlorinated solution at the rate of 0.5 ml/h. The pump had besides the capability of disperse a maximum of 4 bolus/ h, everyone of 0.5 ml, on demand of the patient. The 2 degrees group received a solution containing 60 ml of Morphine in 60 ml of isotonic chlorinated solution with the same formality of administration. The 3 degrees group (placebo) received 60 ml of isotonic chlorinated solution in pumps from infusion and Ketorolac intramuscular on demand. To the times T0 (awakening), T1 (3 h), T2 (6h), T3 (12 h), T4 (24 h), T5 (30 h, was collected algometrical consequences according to VAS (Visual Analogous Scale of Sc modification of the PA increase, FC, FR, SatO2.. The obtained results have highlighted like in the 1 degree group, to the 1 degree algometric consequence (T0), there is a good sedative effect on the pain (intensity of the middle low pain 3.70 +/- 1.64); this antalgic effect has also continued in the other consequences effected in the post-operatory. In the 2 degree group to the awakening (T0), the pain was middle-tall (5.50 +/- 2.32) and an expressive reduction appeared at the time T2 (3.60 +/- 1.35 P < 0.005). In the 3 degrees group have not recorded a diminution of the pain if not after 24 hours from the end of the intervention deposit the intramuscular antalgic therapy. In conclusion, the system infusion + PCA represents an indubitable advantage in comparison with the traditional antalgic therapy as for concern the entity of the reduction of the pain as because it permits the use of a smaller quality of drugs.
Collapse
Affiliation(s)
- G Testa
- Istituto di Anestesiologia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | |
Collapse
|
48
|
Zuccarini F, Bottegoni G, Leombruni E, Filippini A, Bastonno O, Costantini D, Picardi N. [Significance of antibiotic prophylaxis in infection prevention in biliary surgery. Personal experience]. Ann Ital Chir 1995; 66:665-9. [PMID: 8948805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Postoperative infections are one of the most frequent causes of morbidity in surgical patients. In biliary tract surgery the risk of septic complications is essentially increased by opening the bile ducts. Aim of this paper is to evaluate indications and effectiveness of short-term prophylaxis in preventing infective complications of biliary surgery. Authors report a personal six years review regarding 530 patients operated for biliary tract diseases. The patients were divided into two groups: the first one (n. 245) operated under short-term prophylaxis; the second one (n. 285) treated only postoperativelly with antibiotics. The results obtained show a significatively higher rate of infective complications in the second group of patients. There is a little difference between the groups in the case of elective cholecystectomy, whereas there is a great difference in case of non-elective surgery, bile ducts opening, external biliary drainages placement or sphincteropapillotomy. Authors furthermore emphasize how surgical results are conditioned by individual risk factors, especially obesity and diabetes.
Collapse
Affiliation(s)
- F Zuccarini
- I Divisione di Chirurgia, Università degli Studi, G. D'Annunzio di Chieti
| | | | | | | | | | | | | |
Collapse
|
49
|
Costantini D, Tomasello C, Buonopane CE, Sances D, Marandola M, Delogu G. [Treatment of trigeminal neuralgia with electroacupuncture. Experience with 104 cases]. Ann Ital Chir 1995; 66:373-8. [PMID: 8526306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The essential or secondary trigeminal neuralgia is a very frequent and invalidant disease. In this forms, the medical or surgical conventional therapies are often inadequate. In this study we evaluated the effects of the acupunctural therapy on 104 patients (mean age 52.3 +/- 13 years) with idiopathic or secondary trigeminal neuralgia. Utilizing cycles of twelve sessions, the acupunctural treatment was performed with an electrostimulator on local points and a distance or on aching points, in the secondary forms. The results was evaluated on the basis of three parameters (reappearance of the symptomatology, absence of pain in months and preceding treatments) and was defined using this scale: very well, well, fair and null. In conclusion we can say that acupuncture is an elective treatment in all kinds of secondary tregeminal neuralgia, while, in the idiopathic form, its validity is conditioned by preceding medical treatments and by beginning of the disease.
Collapse
Affiliation(s)
- D Costantini
- Istituto di Anestesiologia e Rianimazione, Università degli Studi di Roma La Sapienza
| | | | | | | | | | | |
Collapse
|
50
|
Rizzari C, Conter V, Jankovic M, D'Angelo P, Masera G, Costantini D, Bettinelli ME, Giunta AM. Acute lymphoblastic leukaemia in a child with cystic fibrosis. Haematologica 1992; 77:427-9. [PMID: 1483594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
The association of cystic fibrosis (CF) and acute lymphoblastic leukaemia (ALL) is extremely rare. Only three cases have been reported in the literature and all of them had a fatal outcome. In this paper we describe the case of a little girl who was diagnosed with CF (mild course) when she was five months old, and who presented at the age of five years with ALL (intermediate risk). Complete Remission (CR) was rapidly obtained with standard chemotherapy for ALL.; treatment was continued for two years without major complications and with no apparent influence on the course of CF. The patient remains alive and well and in continuous CR four years after discontinuing treatment, and six years after the diagnosis of ALL.
Collapse
Affiliation(s)
- C Rizzari
- Dipartimento di Ematologia Pediatrica, Università di Milano, Ospedale San Gerardo, Monza, Italy
| | | | | | | | | | | | | | | |
Collapse
|